Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Exosomes vs Polynucleotides for intimate health
Intimate polynucleotides are non-hormonal biostimulatory treatments used in some clinics for vulvovaginal tissue quality. The key decision is whether the symptom has been properly assessed first.
Direct answer
Polynucleotides and exosomes are not the same. Polynucleotides are purified DNA fragments, commonly fish-derived, used as injectable biostimulators; exosomes are extracellular vesicles used in more variable and often less regulated ways. For intimate health, polynucleotides currently have a clearer treatment-material explanation, while exosomes require stronger caution around source, route, sterility and regulatory claims. Neither should replace diagnosis of pain, bleeding, infection or GSM.
The safest plan starts by clarifying the symptom, checking red flags, explaining alternatives and agreeing realistic expectations before any procedure is booked.
Educational only. Suitability must be confirmed after consultation and assessment. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
Polynucleotides at a glance
Non-hormonal biostimulation
Key point 1
Polynucleotides (PNs)
Source
Purified DNA fragments from trout or salmon.
Application
Injectable gel (often combined with hyaluronic acid and mannitol).
Legal Status
Legally compliant, CE-marked medical devices.
Important safety note
Regulatory Red Flag (Exosomes): Injecting exosomes—or using human-derived exosomes for cosmetic purposes—violates federal and statutory regulations in the UK and US. There is no FDA or MHRA-approved exosome product for aesthetic injection.
Allergy
Technique
Timeline
Aftercare
Detailed answer
How polynucleotides fit into intimate care
Polynucleotides are best explained as biostimulatory DNA fragments rather than fillers. The clinical question is whether they match the diagnosis, tissue findings and safety profile.
Not a standard filler
The aim is gradual tissue-quality support through repair signalling, hydration and extracellular-matrix activity, not instant volume or a promised sexual-function outcome.
Evidence
Symptoms
Alternatives
What it means
The Gold Standard: Polynucleotides currently represent the legally compliant, evidence-based gold standard for injectable, non-hormonal intimate tissue regeneration.
Why it happens
Adjunctive Exosome Use: The clinical reality for exosomes is that reputable clinics only use plant or animal-derived exosomes topically, typically smeared into open microchannels immediately following microneedling or fractional laser.
Evidence limits
Treating GSM: Both treatments address Genitourinary Syndrome of Menopause (GSM), a condition affecting up to 70% of postmenopausal women, characterized by severe dryness, tissue fragility, and painful intercourse, which is.
Treatment fit
Procedure Duration: Treatments typically take 30 to 45 minutes in an outpatient clinic setting.
What this means in practice
Procedure Duration: Treatments typically take 30 to 45 minutes in an outpatient clinic setting.
Polynucleotides Timeline: A standard course usually consists of 2 to 3 sessions spaced 2 to 3 weeks apart.
Patient safety
Why diagnosis comes first
Dryness, soreness, tearing or painful sex may reflect GSM, infection, dermatoses, pelvic-floor guarding or medication effects, so the treatment choice depends on assessment.
It checks the cause
The Gold Standard: Polynucleotides currently represent the legally compliant, evidence-based gold standard for injectable, non-hormonal intimate tissue regeneration.
It protects safety
Regulatory Red Flag (Exosomes): Injecting exosomes—or using human-derived exosomes for cosmetic purposes—violates federal and statutory regulations in the UK and US. There is no.
It reviews alternatives
Procedure Duration: Treatments typically take 30 to 45 minutes in an outpatient clinic setting.
It sets expectations
Polynucleotides Timeline: A standard course usually consists of 2 to 3 sessions spaced 2 to 3 weeks apart.
Non-hormonal does not mean automatic
A hormone-free treatment may still be unsuitable if there is active infection, unexplained bleeding, pregnancy, recent surgery, severe fish allergy or unclear pelvic pain.
The consultation should cover product source, allergy risk, alternatives such as moisturisers or local hormonal care, and realistic timelines for tissue response.
Considerations
What to consider
Procedure Duration: Treatments typically take 30 to 45 minutes in an outpatient clinic setting.
Consultation priorities
Consultation: A thorough medical assessment to rule out contraindications (e.g., fish allergies for PNs) and evaluate symptoms of vaginal atrophy or laxity.
Consent
Aftercare
Follow-up
Before treatment
The consultation should check allergy history, intimate symptoms, red flags and whether the comparison is clinically relevant for the patient.
During care
Preparation: Patients must avoid blood-thinning medications (like Aspirin) and alcohol for about a week prior to treatment to minimise bruising.
Aftercare
The Procedure: For PNs, the area is numbed and the gel is injected via fine needles. For exosomes, the area is treated with a device (like Morpheus8V or.
When to reassess
Aftercare Rules: Patients must abstain from sexual intercourse, inserting tampons, rigorous exercise, and extreme heat (saunas, hot baths) for at least 48 to 72 hours (or 3-5 days).
Practical expectations
Polynucleotides Timeline: A standard course usually consists of 2 to 3 sessions spaced 2 to 3 weeks apart.
Pain Management: Topical numbing cream is applied for about 20 minutes prior to polynucleotide injections to ensure minimal discomfort.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: polynucleotides are fillers
Reality: they are biostimulatory DNA fragments, usually used for gradual tissue-quality support rather than volume.
Myth: hormone-free means suitable for everyone
Reality: allergy, infection, bleeding, pregnancy, recent surgery and unexplained pain can still make treatment unsuitable.
Myth: hydration means instant repair
Reality: hydration may be noticed earlier, but collagen and tissue-quality changes are gradual and variable.
Evidence and limits
Mechanism-of-action language should not be treated as proof of a predictable clinical result.
Alternatives still matter
Moisturisers, local hormonal care, pelvic-floor physiotherapy, infection treatment or specialist review may be more appropriate for some patients.
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
Do not claim intimate polynucleotides cure dryness, laxity, sexual dysfunction, pelvic symptoms, scarring or menopause-related tissue change. Explain that PN products are often fish/marine-derived and allergy history matters.
Are alternatives clear?
Procedure Duration: Treatments typically take 30 to 45 minutes in an outpatient clinic setting.
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
Pause treatment for active infection, unexplained bleeding, severe fish allergy, pregnancy, recent pelvic surgery or severe pain that has not been assessed.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Allergy symptoms
Swelling of the lips or tongue, breathing difficulty, widespread hives, faintness or collapse after exposure needs urgent medical help.
Bleeding or infection
New post-menopausal bleeding, unusual discharge, fever, pelvic pain, thrush, BV or UTI symptoms should be assessed before injectable treatment.
Infection signs
Clinic Scrutiny: Beware of exceptionally high-priced or unregulated "stem cell exosome" injections, as these pose serious safety concerns regarding sterility, disease transmission, and lack of Standardisation.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Regulatory resources
Authoritative resources
These sources support cautious, assessment-led patient information and help separate clinical evidence from promotional claims.
PubMed: PN/HA intradermal injections for vulvovaginal atrophy
This pilot study is directly relevant to polynucleotide and hyaluronic acid use in vulvovaginal atrophy.
Real-world study of polynucleotide-based vaginal ovules
This source supports cautious discussion of PN-based vaginal ovules, hydration and atrophy-related symptoms.
NHS guidance on allergies
NHS allergy guidance supports screening and urgent escalation language for fish-derived products.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes, risks and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 69 imported records. Additional reviewed material included peer-reviewed clinical papers, evidence reviews; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
